NO20081481L - Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning - Google Patents
Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivningInfo
- Publication number
- NO20081481L NO20081481L NO20081481A NO20081481A NO20081481L NO 20081481 L NO20081481 L NO 20081481L NO 20081481 A NO20081481 A NO 20081481A NO 20081481 A NO20081481 A NO 20081481A NO 20081481 L NO20081481 L NO 20081481L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- controlled release
- composition containing
- containing carvedilol
- carvedilol
- Prior art date
Links
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004195 carvedilol Drugs 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000010410 layer Substances 0.000 abstract 3
- 239000002702 enteric coating Substances 0.000 abstract 2
- 238000009505 enteric coating Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0500803A HU227490B1 (en) | 2005-08-26 | 2005-08-26 | Sustained release pharmaceutical preparation containing carvedilol |
PCT/HU2006/000068 WO2007023325A2 (en) | 2005-08-26 | 2006-08-23 | Controlled release pharmaceutical composition containing carvedilol |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081481L true NO20081481L (no) | 2008-05-19 |
Family
ID=89986232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081481A NO20081481L (no) | 2005-08-26 | 2008-03-26 | Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1928431B8 (de) |
AT (1) | ATE418969T1 (de) |
DE (1) | DE602006004610D1 (de) |
DK (1) | DK1928431T3 (de) |
EA (1) | EA013058B1 (de) |
ES (1) | ES2321980T3 (de) |
HU (1) | HU227490B1 (de) |
NO (1) | NO20081481L (de) |
PL (1) | PL1928431T3 (de) |
PT (1) | PT1928431E (de) |
WO (1) | WO2007023325A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
ES2646326T3 (es) | 2005-08-03 | 2017-12-13 | Sprout Pharmaceuticals, Inc. | Uso de flibanserina en el tratamiento de la obesidad |
CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
AR062320A1 (es) | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
EA200900270A1 (ru) | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
HU227881B1 (en) * | 2007-02-23 | 2012-05-29 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Sustained release pharmaceutical preparation containing carvedilol |
CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
CN101801357B (zh) | 2007-09-21 | 2013-08-07 | 赢创罗姆有限公司 | 耐受乙醇的影响的pH依赖性受控释放的药物组合物 |
WO2009047800A2 (en) * | 2007-10-09 | 2009-04-16 | Lupin Limited | Oral controlled release composition of carvedilol |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
CN103099793B (zh) * | 2013-02-06 | 2015-07-15 | 中国人民解放军第二军医大学 | 片剂及其制备方法 |
JP7336187B2 (ja) | 2017-11-30 | 2023-08-31 | 日本ケミファ株式会社 | 多層構造を有する粒子状医薬組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004518734A (ja) * | 2000-10-24 | 2004-06-24 | スミスクライン・ビーチャム・コーポレイション | カルベジロールの新規処方 |
DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
AU2003288608A1 (en) * | 2002-12-20 | 2004-07-14 | Ranbaxy Laboratories Limited | Controlled release, multiple unit drug delivery systems |
-
2005
- 2005-08-26 HU HU0500803A patent/HU227490B1/hu not_active IP Right Cessation
-
2006
- 2006-08-23 EP EP06779688A patent/EP1928431B8/de active Active
- 2006-08-23 EA EA200800666A patent/EA013058B1/ru not_active IP Right Cessation
- 2006-08-23 PL PL06779688T patent/PL1928431T3/pl unknown
- 2006-08-23 DK DK06779688T patent/DK1928431T3/da active
- 2006-08-23 AT AT06779688T patent/ATE418969T1/de active
- 2006-08-23 ES ES06779688T patent/ES2321980T3/es active Active
- 2006-08-23 DE DE602006004610T patent/DE602006004610D1/de not_active Expired - Fee Related
- 2006-08-23 WO PCT/HU2006/000068 patent/WO2007023325A2/en active Application Filing
- 2006-08-23 PT PT06779688T patent/PT1928431E/pt unknown
-
2008
- 2008-03-26 NO NO20081481A patent/NO20081481L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007023325A2 (en) | 2007-03-01 |
ES2321980T3 (es) | 2009-06-15 |
EA013058B1 (ru) | 2010-02-26 |
ATE418969T1 (de) | 2009-01-15 |
DE602006004610D1 (de) | 2009-02-12 |
PT1928431E (pt) | 2009-03-25 |
HU227490B1 (en) | 2011-07-28 |
EP1928431A2 (de) | 2008-06-11 |
HUP0500803A2 (en) | 2007-05-29 |
EP1928431B8 (de) | 2009-04-08 |
DK1928431T3 (da) | 2009-04-20 |
EP1928431B1 (de) | 2008-12-31 |
HUP0500803A3 (en) | 2008-03-28 |
PL1928431T3 (pl) | 2009-07-31 |
WO2007023325A3 (en) | 2007-06-28 |
EA200800666A1 (ru) | 2008-06-30 |
HU0500803D0 (en) | 2005-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081481L (no) | Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning | |
WO2011063089A3 (en) | Surface-modified adhesives | |
MX2012008908A (es) | Pelicula que se puede rotular con laser resistente al calor. | |
WO2008132045A3 (en) | Substrates with biocidal coating | |
WO2010017558A3 (en) | Composite material compositions and methods | |
EP2236283A4 (de) | Glieder mit einem korrosionsbeständigen beschichtungsfilm, verfahren zu dessen herstellung und beschichtungszusammensetzung für dessen herstellung | |
WO2011060256A3 (en) | Bilayer tablet formulations | |
ATE538185T1 (de) | Laserempfindliche beschichtungszusammensetzung | |
BR112012013076A2 (pt) | processo para revestir substratos cerâmicos, e, substrato cerâmico. | |
WO2008115890A3 (en) | Mapk/erk kinase inhibitors | |
WO2010112358A3 (de) | Verfahren zur beschichtung einer oberfläche eines bauteils | |
MX2012000656A (es) | Materiales de componentes multiples que tienen una composicion que cambia de color. | |
WO2012163678A3 (de) | Verfahren zur herstellung geschäumter tapeten | |
TW201129652A (en) | Novel use of lipolytic enzyme for formation of anti-fingerprint coating, method of forming anti-fingerprint coating, substrate comprising the anti-fingerprint coating formed by the method, and product comprising the substrate | |
MX2010010053A (es) | Granulos. | |
WO2010029331A3 (en) | Colour forming composition | |
WO2011007285A3 (en) | Multiple component materials having a color-changing composition | |
AR053143A1 (es) | Metodo para preparar un sustrato revestido y sustratos obtenidos | |
WO2008139136A3 (en) | Sensor coating | |
IN2013DN02545A (de) | ||
TW200631791A (en) | Self-adhesive laminate | |
CL2008002551A1 (es) | Aducto amina-funcional; composicion curable, multicomponentes ; sustrato recubierto con dicha composicion; y procedimiento para proveer un recubrimiento a un sustrato | |
JP2009007185A5 (de) | ||
WO2017123381A3 (en) | Antifog coating composition and method of making thereof | |
WO2008092649A3 (de) | Farbige markierung und beschriftung mittels energiereicher strahlung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |